Upregulation of mitochondrial uncoupling protein-2 by the AMP-Activated protein kinase in endothelial cells attenuates oxidative stress in diabetes

156Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.
Get full text

Abstract

OBJECTIVE-Recent evidence suggests that the AMP-activated protein kinase(AMPK) is an important therapeutic target for diabetes. The present study was conducted to determine how AMPK activation suppressed tyrosine nitration of prostacyclin synthase in diabetes. RESEARCH DESIGN AND METHODS-Confluent human umbilical vein endothelial cells(HUVECs) or mice were treated with 5-amino-4-imidazole carboxamide riboside(AICAR) for the detection of AMPK phosphorylation and the expression of mito- chondrial uncoupling protein(UCP)-2. RESULTS-Exposure of HUVECs to high glucose(30 mmol/l) increased superoxide anions(O2-) and prostacyclin synthase nitration. In addition, overexpression of constitutively active AMPK(Ad-CA-AMPK) or the addition of AICAR reduced both O2- and prostacyclin synthase nitration caused by high glucose, whereas adenoviral overexpression of dominant-negative AMPK mutants(Ad-DN-AMPK) enhanced the latter effects of high glucose. Exposure of HUVECs to either AICAR or metformin caused AMPK-dependent upregulation of both UCP-2 mRNA and UCP-2 protein. Furthermore, overexpression of UCP-2 significantly ablated both O2- and prostacyclin synthase nitration triggered by high glucose. Furthermore, overexpression of Ad- CA-AMPK increased, whereas overexpression of Ad-DN-AMPK inhibited AICAR-induced phosphorylation of p38 kinase at Thr180/Tyr182. Inhibition of p38 kinase with SB239063, which had no effect on AICAR-induced AMPK-Thr172 phosphorylation, dose dependently suppressed AICAR-induced upregulation of UCP-2, suggesting that AMPK lies upstream of p38 kinase. Finally, AICAR markedly increased UCP-2 expression and reduced both O2- and prostacyclin synthase nitration in diabetic wild-type mice but not in their AMPKa2-deflcient counterparts in vivo. CONCLUSIONS-We conclude that AMPK activation increases UCP-2, resulting in the inhibition of both O 2- and prostacyclin synthase nitration in diabetes. © 2008 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Xie, Z., Zhang, J., Wu, J., Viollet, B., & Zou, M. H. (2008). Upregulation of mitochondrial uncoupling protein-2 by the AMP-Activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes. American Diabetes Association Inc. https://doi.org/10.2337/db08-0610

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free